Related Experiment Video

Updated: Jun 2, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Beyond treatment volume: when pelvic radiotherapy may still matter in high-risk localised prostate cancer

Iván Henríquez1, Oscar Abuchaibe2, Barbara Malave-Chacon1,3

  • 1Radiation Oncology Department, Institut de Recerca Biomèdica Catalunya Sud (IRB-CS), Hospital Universitari Sant Joan de Reus, Tarragona, Spain.

Frontiers in Oncology
|June 1, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
PSMA PETandrogen receptor pathway inhibitorscN1 diseasegenomicshigh-risk prostate cancermetastasis-free survivalprecision medicinewhole-pelvic radiotherapy

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Stereotactic Radiosurgery for Gynecologic Cancer10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...